SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-11-003121
Filing Date
2011-01-26
Accepted
2011-01-26 16:10:53
Documents
4
Period of Report
2011-01-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a11-4616_18k.htm 8-K 25476
2 EX-99.1 a11-4616_1ex99d1.htm EX-99.1 157020
3 GRAPHIC g46161mm01i001.jpg GRAPHIC 1297
4 GRAPHIC g46161mm01i002.jpg GRAPHIC 4318
  Complete submission text file 0001104659-11-003121.txt   192090
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Filer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19700 | Film No.: 11549563
SIC: 2834 Pharmaceutical Preparations